(±)-α-Tocopherol Acetate-d3 |
An internal standard for the quantification of (±)-α-tocopher… |
1 mg |
30081-1 |
More Info
|
(±)-α-Tocopherol Acetate-d3 |
An internal standard for the quantification of (±)-α-tocopher… |
500 µg |
30081-500 |
More Info
|
(±)-2-Amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (hydrobromide) |
A dopamine receptor agonist (EC50s = 3.5 and 0.65 µM in rat striatal… |
10 mg |
23866-10 |
More Info
|
(±)-2-Amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (hydrobromide) |
A dopamine receptor agonist (EC50s = 3.5 and 0.65 µM in rat striatal… |
25 mg |
23866-25 |
More Info
|
(±)-2-Amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (hydrobromide) |
A dopamine receptor agonist (EC50s = 3.5 and 0.65 µM in rat striatal… |
5 mg |
23866-5 |
More Info
|
(±)-2-Amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene (hydrobromide) |
A dopamine receptor agonist (EC50s = 3.5 and 0.65 µM in rat striatal… |
50 mg |
23866-50 |
More Info
|
(±)-Anabasine (hydrochloride) |
An alkaloid agonist of nAChRs with teratogenic activity; induces depolariz… |
100 mg |
18206-100 |
More Info
|
(±)-Anabasine (hydrochloride) |
An alkaloid agonist of nAChRs with teratogenic activity; induces depolariz… |
50 mg |
18206-50 |
More Info
|
(±)-Anabasine (hydrochloride) |
An alkaloid agonist of nAChRs with teratogenic activity; induces depolariz… |
500 mg |
18206-500 |
More Info
|
(±)-Anatoxin A (fumarate) |
A nicotinic acetylcholine receptor agonist that binds α4β2- and… |
1 mg |
14609-1 |
More Info
|
(±)-Asenapine |
An atypical antipsychotic; binds to dopamine D1-4, α-adrenergic, and… |
1 mg |
9000496-1 |
More Info
|
(±)-Asenapine |
An atypical antipsychotic; binds to dopamine D1-4, α-adrenergic, and… |
10 mg |
9000496-10 |
More Info
|
(±)-Asenapine |
An atypical antipsychotic; binds to dopamine D1-4, α-adrenergic, and… |
5 mg |
9000496-5 |
More Info
|
(±)-Asenapine-13C-d3 (hydrochloride) |
An internal standard for the quantification of (±)-asenapine by GC-… |
1 mg |
31980-1 |
More Info
|
(±)-Atenolol |
A β1-AR antagonist (Ki = 1.14 µM); selective for β1-ARs ov… |
1 g |
17250-1 |
More Info
|
(±)-Atenolol |
A β1-AR antagonist (Ki = 1.14 µM); selective for β1-ARs ov… |
10 g |
17250-10 |
More Info
|
(±)-Atenolol |
A β1-AR antagonist (Ki = 1.14 µM); selective for β1-ARs ov… |
25 g |
17250-25 |
More Info
|
(±)-Atenolol |
A β1-AR antagonist (Ki = 1.14 µM); selective for β1-ARs ov… |
5 g |
17250-5 |
More Info
|
(±)-Atenolol-d7 |
An internal standard for the quantification of (±)-atenolol by GC-… |
1 mg |
30018-1 |
More Info
|
(±)-Atenolol-d7 |
An internal standard for the quantification of (±)-atenolol by GC-… |
10 mg |
30018-10 |
More Info
|
(±)-Atenolol-d7 |
An internal standard for the quantification of (±)-atenolol by GC-… |
25 mg |
30018-25 |
More Info
|
(±)-Atenolol-d7 |
An internal standard for the quantification of (±)-atenolol by GC-… |
5 mg |
30018-5 |
More Info
|
(±)-Baclofen |
A GABAB receptor agonist (IC50 = 180 nM); induces norepinephrine release f… |
1 g |
18600-1 |
More Info
|
(±)-Baclofen |
A GABAB receptor agonist (IC50 = 180 nM); induces norepinephrine release f… |
10 g |
18600-10 |
More Info
|
(±)-Baclofen |
A GABAB receptor agonist (IC50 = 180 nM); induces norepinephrine release f… |
25 g |
18600-25 |
More Info
|
(±)-Baclofen |
A GABAB receptor agonist (IC50 = 180 nM); induces norepinephrine release f… |
5 g |
18600-5 |
More Info
|
(±)-Baclofen |
An analytical reference standard categorized as a gabapentinoid and a noot… |
10 mg |
27326-10 |
More Info
|
(±)-Baclofen |
An analytical reference standard categorized as a gabapentinoid and a noot… |
50 mg |
27326-50 |
More Info
|
(±)-Baclofen-d4 |
An internal standard for the quantification of (±)-baclofen by GC-… |
1 mg |
27811-1 |
More Info
|
(±)-BAY 41-4109 |
A heteroaryldihydropyrimidine with antiviral activity; inhibits HBV replic… |
10 mg |
26907-10 |
More Info
|
(±)-BAY 41-4109 |
A heteroaryldihydropyrimidine with antiviral activity; inhibits HBV replic… |
25 mg |
26907-25 |
More Info
|
(±)-BAY 41-4109 |
A heteroaryldihydropyrimidine with antiviral activity; inhibits HBV replic… |
5 mg |
26907-5 |
More Info
|
(±)-BAY 41-4109 |
A heteroaryldihydropyrimidine with antiviral activity; inhibits HBV replic… |
50 mg |
26907-50 |
More Info
|
(±)-BAY-1251152 |
A racemic mixture of (+)-BAY-1251152 and (-)-BAY-1251152 |
1 mg |
35094-1 |
More Info
|
(±)-BAY-1251152 |
A racemic mixture of (+)-BAY-1251152 and (-)-BAY-1251152 |
10 mg |
35094-10 |
More Info
|
(±)-BAY-1251152 |
A racemic mixture of (+)-BAY-1251152 and (-)-BAY-1251152 |
25 mg |
35094-25 |
More Info
|
(±)-BAY-1251152 |
A racemic mixture of (+)-BAY-1251152 and (-)-BAY-1251152 |
5 mg |
35094-5 |
More Info
|
(±)-BAY-K-8644 |
A Ca2+ channel activator; a racemic mixture of the (R)-(+)-BAY-K-8644 and… |
1 mg |
21479-1 |
More Info
|
(±)-BAY-K-8644 |
A Ca2+ channel activator; a racemic mixture of the (R)-(+)-BAY-K-8644 and… |
10 mg |
21479-10 |
More Info
|
(±)-BAY-K-8644 |
A Ca2+ channel activator; a racemic mixture of the (R)-(+)-BAY-K-8644 and… |
25 mg |
21479-25 |
More Info
|
(±)-BAY-K-8644 |
A Ca2+ channel activator; a racemic mixture of the (R)-(+)-BAY-K-8644 and… |
5 mg |
21479-5 |
More Info
|
(±)-β-Hydroxybutyrate |
An endogenous and specific inhibitor of class I HDACs |
1 g |
14148-1 |
More Info
|
(±)-β-Hydroxybutyrate |
An endogenous and specific inhibitor of class I HDACs |
10 g |
14148-10 |
More Info
|
(±)-β-Hydroxybutyrate |
An endogenous and specific inhibitor of class I HDACs |
5 g |
14148-5 |
More Info
|
(±)-β-Hydroxybutyrate-d4 (sodium salt) |
An internal standard for the quantification of (±)-β-hydroxybu… |
1 mg |
14158-1 |
More Info
|
(±)-β-Hydroxybutyrate-d4 (sodium salt) |
An internal standard for the quantification of (±)-β-hydroxybu… |
10 mg |
14158-10 |
More Info
|
(±)-β-Hydroxybutyrate-d4 (sodium salt) |
An internal standard for the quantification of (±)-β-hydroxybu… |
5 mg |
14158-5 |
More Info
|
(±)-9β-hydroxy Hexahydrocannabinol |
An analytical reference standard that is structurally similar to known syn… |
1 mg |
35266-1 |
More Info
|
(±)-β-Tocopherol |
A lipid-soluble form of vitamin E with antioxidant activity; scavenges DPP… |
50 mg |
26758-50 |
More Info
|
(±)-Blebbistatin |
A racemic mixture of blebbistatin isomers |
10 mg |
13186-10 |
More Info
|